Artoxan 20 mg 10 tablets — Made in Turkey — Free Delivery

Relief of pain and inflammation in osteoarthritis and rheumatoid arthritis.

Short-term treatment of acute diseases of the musculoskeletal system, including sprains, dislocations and other soft tissue injuries.

In case of impossibility of oral administration, tenoxicam is also available in the form for intravenous and intramuscular administration.

Hypersensitivity to the active substance or other components of the preparation.

A history of symptoms of hypersensitivity (including asthma symptoms, rhinitis, angioedema, urticaria) to acetylsalicylic acid and other nonsteroidal anti-inflammatory preparations (NSAIDs).

Recurrent peptic ulcer / bleeding in active form or in history (2 or more severe episodes of peptic ulcer or bleeding).

A history of gastrointestinal bleeding (ground, hematomesis) and perforation associated with previous NSAID therapy, severe gastritis.

History of cerebrovascular bleeding or other bleeding disorders.

Severe heart, hepatic, renal failure.

III trimester of pregnancy.

Breastfeeding period.

Children's age (up to 18 years old).

active substance: tenoxicam;

1 coated tablet contains tenoxicam 20 mg

excipients: lactose monohydrate, corn starch 1500; talc magnesium stearate film coating Opadry® II Yellow 85F220095 (polyvinyl alcohol; macrogol, titanium dioxide (E 171), talc, iron oxide yellow (E172) tartrazine aluminum varnish (E 102), sunset yellow FCF aluminum varnish (E110)).

The preparation is intended for oral administration. The tablets should be taken at the same time daily, during or after meals, with water or other liquid.

Adults.

The recommended dose is 20 mg per day. The recommended doses of the preparation should not be exceeded, since a more pronounced therapeutic effect is not always achieved, and the risk of adverse reactions increases.

The duration of treatment with tenoxicam for acute disorders of the musculoskeletal system usually does not exceed 7 days. In exceptional cases, therapy can be extended up to 14 days.

Children.

There is no data on the safety of the use of tenoxicam in children, therefore, this category of patients should not be used.